C10H12N2O5 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrah ydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-, (2R,3 R,3aS,9aR)- (9CI, ACI)

Souri kanonyal

O = C1N = C2OC3C (O) C (OC3N2C = C1C) CO

Souri izomèr

O [C@H] 1 [C@] 2 ([C@] (N3C (O2) = NC (= O) C (C) = C3) (O [C @@ H] 1CO) [H]) [H]

Inchi

InChI= 1S/C10H12N2O5/c1-4-2-12-9-7(6(14)5(3-13)16-9)17-10(12)11-8(4)15/h2,5-7,9,13-14H,3H2,1H3/t5-,6-,7+,9-/m1/s1

Inchi kle

Wlloaucnumyoqi-jagxhnfqsa-n

17 Lòt non pou sibstans sa a

(2R,3 R, 3aS, 9aR) -2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl) -7-methyl-6H-furo [2 ′, 3 ′: 4,5] oxazolo [3,2-a] Pyrimidin-6-One (ACI);

6H-Furo [2 ′, 3 ′: 4,5] oxazolo [3,2-a] Pyrimidin-6-yon sèl, 2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl) -7-methyl- (6ci, 7ci, 8ci); 6H-Furo

[2 ′, 3 ′: 4,5] oxazolo [3,2-a] Pyrimidin-6-yon sèl, 2,3,3a, 9a-tetrahydro-3-hydroxy-2- (hydroxymethyl) -7-methyl-, [2R- (2α, 3β, 3aβ, 9aβ)]- (ZCI);

11: PN: US20040014699 Paj: 18 reklame ADN; 12: PN: US20040005565 Paj: 17-2 22 reklame ADN; 12: PN: US20040005570 Page: 18 reklame ADN; 12: PN: US20040006029 Paj: 21 reklame ADN; 12: PN: US20040014051 Paj: 21 reklame ADN; 1: PN: WO20050 06958 Paj: 59 reklame ADN; 2,2 ′ -anhydro (1- β-D-arabinofuranosyl)-5-methyluracil; 3: PN: WO2005007825 Paj: 59 reklame ADN; 84: PN: US20040005707 Paj: 18 reklame ADN; 9: PN: US20040014048 Paj: 19 reklame ADN; 9: PN: US20040014049 Paj: 19

reklame ADN;O2,2 ′ -anhydro-5-methyluridine; O2,2 ′ -anhydro-5-methyluridine; TK 112690